BPMC
Neuberger Berman Group’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $310K | Sell |
2,421
-65,373
| -96% | -$8.38M | ﹤0.01% | 1717 |
|
|
2025
Q1 | $6M | Buy |
67,794
+1,399
| +2% | +$124K | 0.01% | 900 |
|
|
2024
Q4 | $5.79M | Buy |
66,395
+2,516
| +4% | +$219K | ﹤0.01% | 921 |
|
|
2024
Q3 | $5.91M | Buy |
63,879
+10,110
| +19% | +$935K | ﹤0.01% | 910 |
|
|
2024
Q2 | $5.8M | Buy |
53,769
+2,461
| +5% | +$265K | ﹤0.01% | 878 |
|
|
2024
Q1 | $4.87M | Buy |
51,308
+8,802
| +21% | +$835K | ﹤0.01% | 932 |
|
|
2023
Q4 | $3.92M | Sell |
42,506
-14,261
| -25% | -$1.32M | ﹤0.01% | 967 |
|
|
2023
Q3 | $2.85M | Buy |
56,767
+366
| +0.6% | +$18.4K | ﹤0.01% | 1008 |
|
|
2023
Q2 | $3.56M | Buy |
56,401
+13,225
| +31% | +$836K | ﹤0.01% | 967 |
|
|
2023
Q1 | $1.94M | Buy |
43,176
+3,736
| +9% | +$168K | ﹤0.01% | 1094 |
|
|
2022
Q4 | $1.73M | Buy |
39,440
+11,477
| +41% | +$503K | ﹤0.01% | 1103 |
|
|
2022
Q3 | $1.84M | Buy |
+27,963
| New | +$1.84M | ﹤0.01% | 1102 |
|
|
2020
Q1 | – | Sell |
-10,000
| Closed | -$801K | – | 1529 |
|
|
2019
Q4 | $801K | Sell |
10,000
-12,500
| -56% | -$1M | ﹤0.01% | 1196 |
|
|
2019
Q3 | $1.65M | Sell |
22,500
-6,100
| -21% | -$448K | ﹤0.01% | 1053 |
|
|
2019
Q2 | $2.7M | Buy |
28,600
+8,600
| +43% | +$811K | ﹤0.01% | 963 |
|
|
2019
Q1 | $1.6M | Buy |
+20,000
| New | +$1.6M | ﹤0.01% | 1010 |
|
|
2018
Q2 | – | Sell |
-9,711
| Closed | -$890K | – | 1706 |
|
|
2018
Q1 | $890K | Sell |
9,711
-289
| -3% | -$26.5K | ﹤0.01% | 1213 |
|
|
2017
Q4 | $754K | Buy |
+10,000
| New | +$754K | ﹤0.01% | 1302 |
|
|
2017
Q2 | – | Sell |
-16,479
| Closed | -$659K | – | 1585 |
|
|
2017
Q1 | $659K | Buy |
16,479
+5,861
| +55% | +$234K | ﹤0.01% | 1231 |
|
|
2016
Q4 | $298K | Buy |
+10,618
| New | +$298K | ﹤0.01% | 1410 |
|